(Q40178426)

18 September 2017

1 reference

title

Muramyl peptides: immunomodulators, sleep factors, and vitamins (English)

1 reference

18 September 2017

Muramyl peptides: Immunomodulators, sleep factors, and vitamins (English)

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

author name string

A. Adam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6374337

11 October 2023

E. Lederer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6374337

11 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6374337

11 October 2023

publication date

1 April 1984

1 reference

full work available at URL

18 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmed.2610040202

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

https://onlinelibrary.wiley.com/doi/full/10.1002/med.2610040202

11 October 2023

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Medicinal Research Reviews

11 October 2023

published in

1 reference

18 September 2017

volume

4

1 reference

18 September 2017

issue

2

1 reference

18 September 2017

page(s)

111-152

1 reference

The Pyrogenicity of the Synthetic Adjuvant Muramyl Dipeptide and Two Structural Analogues

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040202

Enhancement by Muramyl Dipeptide ofin vitroNude Mice Responses to a T-Dependent Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040202

Higher Immunoadjuvant Activities ofN-Acetyl-β-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in Comparison withN-Acetylmuramyl-L-alanyl-D-isoglutamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040202

Isolation procedure and properties of monomer unit from lysozyme digest of peptidoglycan complex excreted into the medium by penicillin-treated Brevibacterium divaricatum mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040202

Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040202

Nonspecific enhancement of resistance to local bacterial infection in starved mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040202

Bayliss-Starling Memorial Lecture (1982). Induction of sleep by muramyl peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040202

Release of 5-Hydroxytryptamine and Morphological Changes in Blood Platelets Induced by Mucopeptide of Streptococcal Cell Walls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040202

In Vivo and in Vitro Stimulation of Nonspecific Immunity by the -D-p-Aminophenyl Glycoside of N-Acetylmuramyl-L-Alanyl-D-Isoglutamine and an Oligomer Prepared by Cross-Linking with Glutaraldehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040202

Isolation and Properties of a Macromolecular, Water-Soluble, Immuno-Adjuvant Fraction from the Cell Wall of Mycobacterium smegmatis

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

A hydrosoluble, adjuvant-active mycobacterial "polysaccharide-peptidoglycan". Preparation by a simple extraction technique of the bacterial cells (strain Peurois)

11 October 2023

5

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity

11 October 2023

6

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Chemical structure of the cell wall of Mycobacterium smegmatis. I — Isolation and partial characterization of the peptidoglycan

11 October 2023

9

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

L'acide N-glycolyl-muramique, constituant des parois de Mycobacterium smegmatis: Identification par spectrometrie de masse

11 October 2023

10

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Adjuvant activity of monomeric bacterial cell wall peptidoglycans.

11 October 2023

11

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

11 October 2023

13

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives

11 October 2023

14

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Synthetic immunostimulants derived from the bacterial cell wall

11 October 2023

19

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds

11 October 2023

21

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Kinetics of the humoral and cellular immune response of guinea pigs after injection of the synthetic adjuvant N-acetylmuramyl L-alanyl-D-isoglutamine: comparison with Freund complete adjuvant

11 October 2023

22

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

23

18

105

Kotani

1975

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Adjuvant Activities in Production of Reaginic Antibody by Bacterial Cell Wall Peptidoglycan or Synthetic N -Acetylmuramyl Dipeptides in Mice

11 October 2023

26

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Target cells for the activity of a synthetic adjuvant: Muramyl dipeptide

11 October 2023

27

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds

11 October 2023

29

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Modulation of the immune response by a synthetic adjuvant and analogs

11 October 2023

31

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Immunosuppressive effect of Staphylococcus aureus peptidoglycan on antibody response in mice

11 October 2023

32

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

In vivo regulation of humoral and cellular immune reponses of mice by a synthetic adjuvant, N-acetyl-muramyl-l-alanyl-d-isoglutamine, muramyl dipeptide for MDP

11 October 2023

33

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Stimulation of the reticuloendothelial system of mice by muramyl dipeptide

11 October 2023

35

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs

11 October 2023

39

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide

11 October 2023

41

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice.

11 October 2023

43

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Studies on cell walls of Mycobacteria. I. Chemical and biological properties of the cell walls and the mucopeptide of BCG

11 October 2023

44

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs.

11 October 2023

49

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide

11 October 2023

51

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants

11 October 2023

52

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Augmentation of mouse natural killer cell activity by muramyl dipeptide and its analogs

11 October 2023

54

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Structural specificity of synthetic peptide adjuvant for induction of experimental allergic encephalomyelitis

11 October 2023

55

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Minimum structural requirements for encephalitogen and for adjuvant in the induction of experimental allergic encephalomyelitis

11 October 2023

56

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

62

19

9

Kotani

1976

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Central pyrogenic activity of muramyl dipeptide

11 October 2023

64

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide

11 October 2023

65

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Induction of delayed type hypersensitivity-like skin reaction by peptidoglycans of bacterial cell walls

11 October 2023

66

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Experimental Cell Biology

11 October 2023

70

44

83

Ohkuni

1976

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

IMMUNOLOGICAL PROPERTIES OF BACTERIAL CELL WALL MUCOPEPTIDES

11 October 2023

71

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Immunochemical Study of the Peptidoglycan of Gram-Negative Bacteria

11 October 2023

72

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Synthesis of conjugates containing N-acetylmuramyl-L-alanyl-D-isoglutaminyl (MDP). Their use as hapten-carrier systems

11 October 2023

73

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide

11 October 2023

75

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Macrophage activation by muramyl dipeptide as measured by macrophage spreading and attachment

11 October 2023

76

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP)

11 October 2023

77

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Inhibition of macrophage migration by synthetic muramyl dipeptide

11 October 2023

78

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Effect of synthetic muramyl dipeptide (MDP) on differentition of myeloid leukemic cells

11 October 2023

79

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Macrophage activation by bacterial cell walls and related synthetic compounds

11 October 2023

82

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Effect of muramyldipeptide, a synthetic bacterial adjuvant, on enzyme release from cultured mouse macrophages

11 October 2023

83

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

Cancer Treatment Reports

85

62

1981

Hadden

1978

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Stimulation by conditioned medium of L-929 fibroblasts, E. coli lipopolysaccharide, and muramyl dipeptide of candidacidal activity of mouse macrophages

11 October 2023

86

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Inhibition of macrophage phagocytic activity by group A streptococcal cell walls

11 October 2023

87

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide

11 October 2023

89

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Macrophage-stimulating effect of a synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T-cell activating monokines

11 October 2023

91

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor

11 October 2023

92

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Stimulation of thymocyte mitogenic protein secretion and of cytostatic activity of mouse peritoneal macrophages by trehalose dimycolate and muramyldipeptide

11 October 2023

94

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Mitogenic activity of the cell walls of mycobacteria, nocardia, corynebacteria and anaerobic coryneforms

11 October 2023

95

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Mitogenic Effects of Bacterial Cell Walls, Their Fragments, and Related Synthetic Compounds on Thymocytes and Splenocytes of Guinea Pigs

11 October 2023

97

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Polyclonal B cell activation by cell wall preparations of gram-positive bacteria. In vitro responses of spleen cells obtained from Balb/c, nu/nu, nu/+, C3H/He, C3H/HeJ and hybrid (DBA/N x Balb/c)F1 mice

11 October 2023

98

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Dissociation between the adjuvant vs mitogenic activity of a synthetic muramyl dipeptide for murine splenocytes

11 October 2023

99

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: Evidence of initial target cells for the adjuvant activity

11 October 2023

102

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Inhibitory and stimulatory effects of a synthetic glycopeptide (MDP) on the in vitro PFC response: Factors affecting the response

11 October 2023

103

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

On the mechanism of early recovery of specifically depleted lymphoid cell populations by nonspecific activation of T cells

11 October 2023

105

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Adjuvant activity of synthetic N-acetylmuramyl-l-alanyl-d-isoglutamine and related compounds on cell-mediated cytotoxicity in syngeneic mice

11 October 2023

106

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

107

35

666

Sharma

1975

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Influence of MDP and of some analogous synthetic glycopeptides on the in vitro mouse spleen cell viability and immune response to sheep erythrocytes

11 October 2023

113

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall

11 October 2023

115

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

117

20

5

Kotani

1977

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

The immunological activities of bacterial peptidoglycans

11 October 2023

120

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Sleep-promoting effects of muramyl peptides.

11 October 2023

122

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Muramyl peptides. Chemical structure, biological activity and mechanism of action

11 October 2023

125

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Synthesis of N-acetyl-muramyl-L-alanyl-D-isoglutamine, an adjuvant of the immune response, and of some n-acetyl-muramyl-peptide analogs

11 October 2023

127

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine)

11 October 2023

128

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Synthesis of carbohydrate analogs (positional, configurational, and optical) of n-acetylmuramoyl-L-alanyl-D-isoglutamine, and their immunoadjuvant activities

11 October 2023

135

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers

11 October 2023

140

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Synthesis and immunoadjuvant activities of 2-acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O-[(R)-2-propionyl-L-alanyl-D- isoglutamine]-D-glucofuranoses as potential prodrug forms of 6-O-Acyl Derivatives of N-acetylmuramyl dipeptide

11 October 2023

142

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

146

4013

Durette

1979

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

13C-N.m.r. studies of a natural immunoadjuvant, peptidoglycan monomer and related compounds

11 October 2023

148

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Immunotherapy of B-16 melanoma with peptidoglycan monomer

11 October 2023

149

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Chemical structure required for immunoadjuvant and arthritogenic activities of cell wall peptidoglycans

11 October 2023

150

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil

11 October 2023

151

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds

11 October 2023

152

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs

11 October 2023

154

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Novel quinonyl derivatives of muramyl dipeptide possessing potent antitumor activity

11 October 2023

156

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.

11 October 2023

158

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Adjuvant Activity of Mycoloyl Derivatives of N-Acetylmuramyl-L-alanyl-D-isoglutamine in Mice and Guinea Pigs

11 October 2023

159

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine

11 October 2023

160

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides

11 October 2023

165

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity

11 October 2023

166

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

167

39

4756

Ribi

1979

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Dissociation of immunostimulant activities of muramyl dipeptide (MDP) by linking amino-acids or peptides to the glutaminyl residue

11 October 2023

168

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

A short lipopeptide, representative of a new family of immunological adjuvants devoid of sugar

11 October 2023

170

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

N2-(gamma-D-Glutamyl)-meso-2(L),2'(D)-diaminopimelic acid as the minimal prerequisite structure of FK-156: its acyl derivatives with potent immunostimulating activity.

11 October 2023

173

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan

11 October 2023

180

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Streptococcal cell walls and synovial cell activation. Stimulation of synovial fibroblast plasminogen activator activity by monocytes treated with group A streptococcal cell wall sonicates and muramyl dipeptide

11 October 2023

184

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Adjuvants for secretory immune responses

11 October 2023

185

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Effect of adjuvants on orally administered antigens

11 October 2023

186

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components

11 October 2023

187

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions

11 October 2023

188

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Demonstration of muramyl dipeptide (MDP)-induced T suppressor cells responsible for MDP immunosuppressive activity

11 October 2023

189

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Enhancement of antigen-specific suppression by muramyl dipeptide

11 October 2023

190

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

The macrophage, target cell of the synthetic adjuvant muramyl dipeptide

11 October 2023

192

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

In vitro immune response to sheep erythrocytes in macrophage depleted cultures. Restoration with interleukine 1 or a monokine from resident macrophages and stimulation by N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP)

11 October 2023

193

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide

11 October 2023

197

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide

11 October 2023

198

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Inhibition of macrophage migration by muramyl peptides

11 October 2023

201

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Different effect of (L)-fucose binding lectin on macrophage migration inhibition caused by guinea pig migration inhibitory factor and synthetic muramyl dipeptide.

11 October 2023

202

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Differences between macrophage migration inhibitions by lymphokines and muramyl dipeptide (MDP) or lipopolysaccharide (LPS): migration enhancement by lymphokines

11 October 2023

203

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Modulation of myelopoiesis by different bacterial cell-wall components: induction of colony-stimulating activity (by pure preparations, low-molecular-weight degradation products, and a synthetic low-molecular analog of bacterial cell-wall components

11 October 2023

205

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivative

11 October 2023

207

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Amyloidosis and the serum amyloid A protein response to muramyl dipeptide analogs and different mycobacterial species

11 October 2023

208

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Stimulating effect of MDP and its adjuvant-active analogues on guinea pig fibroblasts for the production of thymocyte-activating factor

11 October 2023

210

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant

11 October 2023

211

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.

11 October 2023

212

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes

11 October 2023

216

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

218

43

2010

Kleinerman

1983

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Immunization against malaria with antigen from Plasmodium falciparum cultivated in vitro

11 October 2023

223

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Vaccination of Experimental Monkeys Against Plasmodium falciparum : A Possible Safe Adjuvant

11 October 2023

225

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection

11 October 2023

228

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Effective immunity to dental caries: enhancement of salivary anti-Streptococcus mutans antibody responses with oral adjuvants

11 October 2023

230

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Tapping the immunological repertoire to produce antibodies of predetermined specificity

11 October 2023

231

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

From synthetic antigens to synthetic vaccines

11 October 2023

232

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Chemically Defined Antiviral Vaccines

11 October 2023

233

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Antiviral response elicited by a completely synthetic antigen with built-in adjuvanticity

11 October 2023

234

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Active antitoxic immunization by a diphtheria toxin synthetic oligopeptide

11 October 2023

235

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Successful immunization with a totally synthetic diphtheria vaccine

11 October 2023

236

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Immunological castration of male mice by a totally synthetic vaccine administered in saline

11 October 2023

237

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides

11 October 2023

239

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Non-specific stimulation of host defenses against a bacterial challenge in malnourished hosts

11 October 2023

241

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Protective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infection

11 October 2023

242

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Journal of General Microbiology

11 October 2023

246

128

2361

Osada

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Systemic activation of macrophages by liposome-entrapped muramyl tripeptide in mice pretreated with the chemotherapeutic agent adriamycin

11 October 2023

248

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Failure of synthetic muramyl dipeptide to increase antibacterial resistance

11 October 2023

250

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Regression of tumors in guinea pigs after treatment with synthetic muramyl dipeptides and trehalose dimycolate

11 October 2023

258

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate.

11 October 2023

259

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

261

41

2654

Takayama

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

263

42

496

Fidler

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Prostaglandin D2 induces sleep when microinjected into the preoptic area of conscious rats.

11 October 2023

265

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Prostaglandin D2, a cerebral sleep-inducing substance in rats

11 October 2023

266

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Fate of two 14C labelled muramyl peptides: Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm and Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm-D-Ala-D-Ala in mice. Evaluation of their ability to increase non specific resistance to Klebsiella infection

11 October 2023

273

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Partial purification and characterization of N-acetylmuramyl-L-alanine amidase from human and mouse serum

11 October 2023

274

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

Partial purification and characterization of N-acetylmuramyl-L-alanine amidase from human and mouse serum

11 October 2023

275

1 reference

https://api.crossref.org/works/10.1002/MED.2610040202

11 October 2023

Identifiers

1 reference

18 September 2017

1 reference